Morepen Laboratories, 500288, MOREPENLAB Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

2,945.80
31.81
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

2,975.83
0.37%
2.52

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

14.08
8.80
8.52

EBITDA CAGR (%)

10 Years
5 Years
3 Years

10.95
7.99
16.96

PAT CAGR (%)

10 Years
5 Years
3 Years

24.88
3.98
45.04

P:E (Median)

8 Years
5 Years
3 Years

28.87
27.94
31.52

P:BV (Average)

8 Years
5 Years
3 Years

3.76
3.45
2.76

EV:EBITDA (Average)

8 Years
5 Years
3 Years

15.80
16.60
17.43

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 391.28 385.64 1.46% 381.94 392.60 -2.72% 403.25 394.63 2.18% 383.70 381.26 0.64%
Expenses 372.33 337.03 10.47% 351.78 336.46 4.55% 371.68 343.52 8.20% 340.63 351.50 -3.09%
EBITDA 18.95 48.61 -61.02% 30.16 56.14 -46.28% 31.58 51.12 -38.22% 43.06 29.76 44.69%
EBIDTM 4.84% 12.60% 7.90% 14.30% 7.83% 12.95% 11.22% 7.81%
Other Income 4.09 3.07 33.22% 3.14 3.99 -21.30% 4.87 3.66 33.06% 4.63 2.84 63.03%
Interest 3.81 1.04 266.35% 3.74 0.73 412.33% 1.27 2.04 -37.75% 1.05 0.45 133.33%
Depreciation 7.88 3.59 119.50% 12.25 6.69 83.11% 4.81 5.51 -12.70% 3.79 4.81 -21.21%
PBT 11.35 47.05 -75.88% 17.30 52.71 -67.18% 30.38 47.22 -35.66% 42.86 27.33 56.82%
Tax 3.29 12.00 -72.58% 5.39 12.75 -57.73% 7.69 12.02 -36.02% 10.93 7.41 47.50%
PAT 8.06 35.05 -77.00% 11.91 39.96 -70.20% 22.69 35.20 -35.54% 31.93 19.92 60.29%
PATM 2.06% 9.09% 3.12% 10.18% 5.63% 8.92% 8.32% 5.23%
EPS 0.15 0.64 -76.56% 0.22 0.73 -69.86% 0.41 0.64 -35.94% 0.58 0.36 61.11%

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 425.24 455.22 -6.59% 465.85 423.07 10.11% 452.78 444.55 1.85% 437.73 421.77 3.78%
Expenses 401.07 403.60 -0.63% 423.61 374.69 13.06% 416.64 393.99 5.75% 393.66 388.18 1.41%
EBITDA 24.17 51.62 -53.18% 42.24 48.38 -12.69% 36.14 50.57 -28.53% 44.07 33.59 31.20%
EBIDTM 5.68% 11.34% 9.07% 11.44% 7.98% 11.37% 10.07% 7.96%
Other Income 4.41 3.43 28.57% 4.61 4.24 8.73% 5.34 4.07 31.20% 4.99 3.24 54.01%
Interest 4.04 1.15 251.30% 4.67 0.80 483.75% 1.34 2.17 -38.25% 1.18 0.46 156.52%
Depreciation 9.03 5.73 57.59% 16.47 9.62 71.21% 4.93 8.45 -41.66% 1.86 7.69 -75.81%
PBT 15.52 48.17 -67.78% 25.71 42.20 -39.08% 35.20 44.02 -20.04% 46.02 28.68 60.46%
Tax 4.11 12.00 -65.75% 5.40 13.46 -59.88% 8.52 12.03 -29.18% 11.17 7.43 50.34%
PAT 11.40 36.17 -68.48% 20.31 28.74 -29.33% 26.69 31.99 -16.57% 34.85 21.26 63.92%
PATM 2.68% 7.95% 4.36% 6.79% 5.89% 7.20% 7.96% 5.04%
EPS 0.20 0.71 -71.83% 0.37 0.55 -32.73% 0.49 0.63 -22.22% 0.64 0.42 52.38%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 1,560.17 1,554.54 1,537.59 1,338.88 1,449.27 1,112.42 791.99 717.24 560.83 547.51 452.46 Net Sales Growth 0.39% 1.10% 14.84% -7.62% 30.28% 40.46% 10.42% 27.89% 2.43% 21.01% Cost Of Goods Sold 992.87 929.43 904.73 847.50 921.58 691.36 487.87 448.98 335.30 328.24 273.04 Gross Profit 567.30 625.10 632.87 491.39 527.68 421.06 304.13 268.26 225.52 219.27 179.42 GP Margin 36.36% 40.21% 41.16% 36.70% 36.41% 37.85% 38.40% 37.40% 40.21% 40.05% 39.65% Total Expenditure 1,436.42 1,401.12 1,375.77 1,261.61 1,320.13 1,000.05 727.52 652.22 500.56 487.02 388.26 Power & Fuel Cost - 40.62 34.09 23.78 18.93 13.00 12.56 13.18 11.08 9.84 7.64 % Of Sales - 2.61% 2.22% 1.78% 1.31% 1.17% 1.59% 1.84% 1.98% 1.80% 1.69% Employee Cost - 177.22 160.28 146.19 150.00 123.20 98.07 84.74 68.22 60.79 51.67 % Of Sales - 11.40% 10.42% 10.92% 10.35% 11.07% 12.38% 11.81% 12.16% 11.10% 11.42% Manufacturing Exp. - 102.33 95.50 91.66 98.96 66.82 48.90 31.27 16.21 15.05 13.33 % Of Sales - 6.58% 6.21% 6.85% 6.83% 6.01% 6.17% 4.36% 2.89% 2.75% 2.95% General & Admin Exp. - 60.29 58.56 50.41 35.93 29.69 31.93 31.21 24.35 21.53 15.34 % Of Sales - 3.88% 3.81% 3.77% 2.48% 2.67% 4.03% 4.35% 4.34% 3.93% 3.39% Selling & Distn. Exp. - 70.00 99.15 84.91 44.90 44.09 35.75 31.72 29.13 29.04 19.87 % Of Sales - 4.50% 6.45% 6.34% 3.10% 3.96% 4.51% 4.42% 5.19% 5.30% 4.39% Miscellaneous Exp. - 21.23 23.47 17.16 49.84 31.89 12.45 11.11 16.26 22.53 19.87 % Of Sales - 1.37% 1.53% 1.28% 3.44% 2.87% 1.57% 1.55% 2.90% 4.11% 1.63% EBITDA 123.75 153.42 161.82 77.27 129.14 112.37 64.47 65.02 60.27 60.49 64.20 EBITDA Margin 7.93% 9.87% 10.52% 5.77% 8.91% 10.10% 8.14% 9.07% 10.75% 11.05% 14.19% Other Income 16.73 15.72 12.57 5.76 20.03 11.77 9.42 3.67 3.54 3.72 1.17 Interest 9.87 7.10 3.51 1.98 2.43 1.79 1.97 2.07 4.29 7.47 10.41 Depreciation 28.73 24.44 21.90 18.01 21.19 28.11 34.43 38.01 33.40 33.56 34.92 PBT 101.89 137.59 148.98 63.04 125.54 94.25 37.48 28.61 26.12 23.17 20.04 Tax 27.30 36.01 38.04 16.80 24.48 0.00 5.15 0.00 0.00 0.00 -0.14 Tax Rate 26.79% 26.17% 25.53% 26.65% 19.50% 0.00% 13.74% 0.00% 0.00% 0.00% -0.90% PAT 74.59 101.58 110.94 46.24 101.06 94.25 32.33 28.61 26.12 23.17 15.78 PAT before Minority Interest 74.59 101.58 110.94 46.24 101.06 94.25 32.33 28.61 26.12 23.17 15.78 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 4.78% 6.53% 7.22% 3.45% 6.97% 8.47% 4.08% 3.99% 4.66% 4.23% 3.49% PAT Growth -42.68% -8.44% 139.92% -54.25% 7.23% 191.52% 13.00% 9.53% 12.73% 46.83% EPS 1.36 1.85 2.02 0.84 1.84 1.72 0.59 0.52 0.48 0.42 0.29

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 1,781.60 1,811.58 1,690.43 1,417.53 1,546.83 1,188.06 853.07 768.54 606.51 595.47 485.08 Net Sales Growth 2.12% 7.17% 19.25% -8.36% 30.20% 39.27% 11.00% 26.72% 1.85% 22.76% Cost Of Goods Sold 1,138.86 1,113.11 1,016.87 900.22 980.35 735.29 524.19 479.12 361.28 358.35 293.33 Gross Profit 642.74 698.47 673.56 517.31 566.47 452.77 328.87 289.42 245.23 237.12 191.76 GP Margin 36.08% 38.56% 39.85% 36.49% 36.62% 38.11% 38.55% 37.66% 40.43% 39.82% 39.53% Total Expenditure 1,634.98 1,637.51 1,531.81 1,338.00 1,410.15 1,069.54 784.55 701.02 541.78 534.09 423.52 Power & Fuel Cost - 40.62 34.09 23.78 18.93 13.00 12.56 13.18 11.08 9.84 7.64 % Of Sales - 2.24% 2.02% 1.68% 1.22% 1.09% 1.47% 1.71% 1.83% 1.65% 1.57% Employee Cost - 208.91 181.47 154.68 164.25 135.59 109.91 95.36 76.53 69.69 58.29 % Of Sales - 11.53% 10.74% 10.91% 10.62% 11.41% 12.88% 12.41% 12.62% 11.70% 12.02% Manufacturing Exp. - 102.62 95.75 91.70 98.99 67.21 48.92 31.28 16.21 22.36 13.33 % Of Sales - 5.66% 5.66% 6.47% 6.40% 5.66% 5.73% 4.07% 2.67% 3.76% 2.75% General & Admin Exp. - 67.17 66.63 55.44 42.38 34.71 36.47 36.14 28.52 18.11 18.14 % Of Sales - 3.71% 3.94% 3.91% 2.74% 2.92% 4.28% 4.70% 4.70% 3.04% 3.74% Selling & Distn. Exp. - 79.99 109.98 93.01 53.58 49.66 40.11 32.73 30.04 25.79 23.45 % Of Sales - 4.42% 6.51% 6.56% 3.46% 4.18% 4.70% 4.26% 4.95% 4.33% 4.83% Miscellaneous Exp. - 25.09 27.02 19.17 51.67 34.08 12.39 13.20 18.11 29.95 23.45 % Of Sales - 1.38% 1.60% 1.35% 3.34% 2.87% 1.45% 1.72% 2.99% 5.03% 1.93% EBITDA 146.62 174.07 158.62 79.53 136.68 118.52 68.52 67.52 64.73 61.38 61.56 EBITDA Margin 8.23% 9.61% 9.38% 5.61% 8.84% 9.98% 8.03% 8.79% 10.67% 10.31% 12.69% Other Income 19.35 18.36 13.97 6.13 20.10 12.07 9.48 3.67 3.72 3.72 1.20 Interest 11.23 8.34 3.71 1.98 2.43 1.79 1.98 2.11 4.36 7.56 10.50 Depreciation 32.29 28.98 33.47 27.93 27.64 30.28 36.91 39.90 34.32 33.90 35.20 PBT 122.45 155.11 135.42 55.76 126.70 98.51 39.11 29.18 29.77 23.63 17.06 Tax 29.20 37.09 38.80 17.08 25.02 1.42 5.53 0.34 0.00 0.00 -0.13 Tax Rate 23.85% 23.91% 28.65% 30.63% 19.75% 1.44% 14.14% 1.17% 0.00% 0.00% -1.03% PAT 93.25 118.03 96.16 38.68 101.68 97.09 33.58 28.85 29.59 23.63 12.80 PAT before Minority Interest 92.59 118.02 96.62 38.68 101.68 97.09 33.58 28.84 29.77 23.63 12.80 Minority Interest -0.66 0.01 -0.46 0.00 0.00 0.00 0.00 0.01 -0.18 0.00 0.00 PAT Margin 5.23% 6.52% 5.69% 2.73% 6.57% 8.17% 3.94% 3.75% 4.88% 3.97% 2.64% PAT Growth -21.08% 22.74% 148.60% -61.96% 4.73% 189.13% 16.40% -2.50% 25.22% 84.61% EPS 1.70 2.15 1.75 0.71 1.86 1.77 0.61 0.53 0.54 0.43 0.23

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 1,181.50 889.02 780.11 598.17 444.97 307.25 277.46 250.56 224.34 328.85 Share Capital 109.58 102.23 102.23 95.56 89.96 89.96 89.96 89.96 89.96 209.61 Total Reserves 1,071.92 786.80 677.89 476.36 311.26 217.29 187.50 160.60 134.38 119.24 Non-Current Liabilities 78.15 37.65 34.45 32.41 26.89 25.36 21.11 17.87 15.28 55.22 Secured Loans 5.76 3.36 0.93 1.32 0.83 0.92 1.79 2.70 0.94 42.74 Unsecured Loans 20.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 36.40 31.60 28.87 26.64 24.01 22.38 17.85 13.45 12.69 10.71 Current Liabilities 461.56 352.63 290.98 402.69 375.63 329.38 320.82 322.21 308.19 150.78 Trade Payables 338.41 267.43 213.10 217.32 192.33 158.38 157.08 164.89 116.20 107.48 Other Current Liabilities 59.51 38.66 39.79 159.63 163.93 157.39 153.61 156.05 190.70 39.14 Short Term Borrowings 46.04 23.49 23.18 16.13 15.32 11.36 8.99 0.00 0.00 0.00 Short Term Provisions 17.60 23.05 14.91 9.61 4.05 2.25 1.14 1.26 1.29 4.16 Total Liabilities 1,721.21 1,279.30 1,105.54 1,033.27 847.49 661.99 619.39 590.64 547.81 534.85 Net Block 365.87 216.54 170.82 156.11 144.02 134.84 152.59 182.10 191.29 216.36 Gross Block 648.76 477.36 512.07 479.46 516.17 641.54 777.14 890.30 922.26 914.18 Accumulated Depreciation 282.88 260.83 341.25 323.35 372.14 506.70 624.55 708.20 730.96 697.82 Non Current Assets 614.42 436.40 374.69 356.50 354.71 313.73 336.06 363.54 369.25 387.98 Capital Work in Progress 28.34 24.45 17.01 14.15 1.96 0.00 0.00 0.00 0.00 0.00 Non Current Investment 127.17 126.18 117.84 117.79 118.78 118.78 117.69 117.69 117.69 117.69 Long Term Loans & Adv. 92.81 68.99 68.74 68.17 89.67 59.83 65.49 63.47 59.41 53.92 Other Non Current Assets 0.23 0.24 0.28 0.28 0.27 0.28 0.28 0.27 0.85 0.00 Current Assets 1,106.78 842.91 730.85 676.76 492.79 348.26 283.33 227.11 178.56 146.88 Current Investments 77.81 0.00 0.00 0.00 0.00 0.00 0.02 0.22 0.00 0.00 Inventories 286.39 220.15 211.35 258.25 169.61 132.47 90.84 73.94 62.50 40.82 Sundry Debtors 293.75 316.89 255.47 221.87 155.52 121.41 121.96 110.22 83.10 80.35 Cash & Bank 46.33 50.48 55.90 45.55 66.98 38.03 31.98 5.70 6.75 3.63 Other Current Assets 402.50 16.27 4.97 5.07 100.68 56.35 38.52 37.02 26.22 22.08 Short Term Loans & Adv. 331.19 239.12 203.16 146.02 90.88 50.45 30.80 31.53 21.67 16.27 Net Current Assets 645.23 490.27 439.87 274.07 117.16 18.88 -37.49 -95.10 -129.63 -3.91 Total Assets 1,721.20 1,279.31 1,105.54 1,033.26 847.50 661.99 619.39 590.65 547.81 534.86

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 1,156.23 847.23 752.91 578.56 424.75 284.06 253.09 225.94 196.26 300.28 Share Capital 109.58 102.23 102.23 95.56 89.96 89.96 89.96 89.96 89.96 209.61 Total Reserves 1,046.65 745.00 650.68 456.75 291.04 194.10 163.13 135.98 106.30 90.67 Non-Current Liabilities 90.49 43.93 36.88 35.50 30.06 28.42 23.38 20.20 17.80 57.47 Secured Loans 5.76 3.36 0.93 1.32 0.83 0.92 1.83 2.95 1.38 43.41 Unsecured Loans 20.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 39.85 33.82 29.74 28.24 25.39 23.82 19.01 14.42 13.59 11.34 Current Liabilities 500.65 402.04 321.16 456.46 403.80 351.44 339.17 340.12 324.86 166.56 Trade Payables 363.30 295.03 226.88 258.12 208.85 172.30 168.15 174.88 124.88 115.33 Other Current Liabilities 71.72 58.51 54.86 169.97 174.38 165.06 160.64 163.90 198.65 47.04 Short Term Borrowings 46.04 23.49 23.18 16.13 15.32 11.36 8.99 0.00 0.00 0.00 Short Term Provisions 19.60 25.02 16.24 12.24 5.25 2.72 1.39 1.33 1.33 4.19 Total Liabilities 1,778.10 1,293.20 1,110.49 1,070.06 858.15 663.46 615.18 585.81 538.29 523.68 Net Block 488.51 307.35 266.97 251.80 224.52 216.37 236.21 264.29 271.80 296.72 Gross Block 828.38 620.63 656.24 613.25 628.32 752.55 887.76 997.60 1,026.96 1,018.43 Accumulated Depreciation 339.87 313.28 389.27 361.45 403.79 536.18 651.55 733.31 755.15 721.72 Non Current Assets 618.73 404.16 354.33 335.75 331.36 291.29 315.71 342.37 346.34 366.53 Capital Work in Progress 28.34 24.45 17.01 14.15 1.96 0.00 0.00 0.00 0.00 0.00 Non Current Investment 7.17 1.30 0.00 0.00 1.08 1.08 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 94.47 70.82 70.07 69.53 103.52 73.55 79.22 77.81 73.69 69.82 Other Non Current Assets 0.23 0.24 0.28 0.28 0.27 0.28 0.28 0.27 0.85 0.00 Current Assets 1,159.37 889.04 756.16 734.30 526.79 372.18 299.47 243.44 191.95 157.15 Current Investments 77.81 0.00 0.00 0.00 0.00 0.00 0.02 0.22 0.00 0.00 Inventories 299.96 248.59 228.89 275.85 175.33 138.48 94.20 76.89 64.66 42.14 Sundry Debtors 324.76 324.94 263.25 250.64 181.98 137.68 133.75 121.85 92.95 87.94 Cash & Bank 49.36 52.12 56.31 45.97 67.89 38.88 32.21 5.95 7.59 4.36 Other Current Assets 407.48 16.44 7.15 5.29 101.59 57.14 39.29 38.54 26.74 22.71 Short Term Loans & Adv. 335.97 246.96 200.58 156.54 91.58 51.16 31.43 32.92 22.03 16.77 Net Current Assets 658.72 487.00 435.00 277.84 122.99 20.73 -39.70 -96.68 -132.92 -9.41 Total Assets 1,778.10 1,293.20 1,110.49 1,070.05 858.15 663.47 615.18 585.81 538.29 523.68

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 29.08 77.36 -102.12 -68.87 49.31 10.86 14.58 61.25 49.24 50.01 PBT 137.59 148.98 63.04 125.54 94.25 37.48 28.61 26.12 22.55 20.04 Adjustment 31.93 22.70 18.01 13.02 29.63 34.23 38.36 37.86 40.92 45.32 Changes in Working Capital -104.37 -56.96 -166.90 -183.04 -74.56 -55.33 -52.40 -2.72 -14.23 -11.09 Cash after chg. in Working capital 65.15 114.72 -85.84 -44.47 49.31 16.38 14.58 61.25 49.24 54.27 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -36.07 -37.36 -16.27 -24.39 0.00 -5.52 0.00 0.00 0.00 0.14 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -4.40 Cash From Investing Activity -280.42 -83.60 -36.20 -22.64 -69.09 -12.08 -10.34 -24.28 -14.67 -27.08 Net Fixed Assets -175.29 27.27 -35.47 24.52 123.41 135.60 113.16 31.96 -8.08 -7.02 Net Investments -78.80 -8.34 -0.05 0.99 0.00 -1.07 0.20 -0.22 0.00 0.25 Others -26.33 -102.53 -0.68 -48.15 -192.50 -146.61 -123.70 -56.02 -6.59 -20.31 Cash from Financing Activity 260.47 0.28 144.20 66.41 47.46 4.65 -0.35 -37.67 -31.29 -27.89 Net Cash Inflow / Outflow 9.12 -5.96 5.88 -25.09 27.68 3.43 3.89 -0.69 3.29 -4.97 Opening Cash & Equivalents 15.30 21.26 15.38 40.47 12.79 9.36 5.47 6.16 2.87 8.60 Closing Cash & Equivalent 24.43 15.30 21.26 15.38 40.47 12.79 9.36 5.47 6.16 3.63

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 32.06 73.37 -91.17 -60.24 50.83 11.02 17.37 63.41 40.73 50.07 PBT 155.11 135.42 55.76 126.70 98.51 39.11 29.18 29.77 23.04 17.06 Adjustment 37.79 34.20 27.90 19.46 31.96 36.63 40.32 38.64 41.40 45.69 Changes in Working Capital -123.69 -58.12 -158.28 -181.47 -78.18 -58.84 -51.78 -5.00 -23.72 -8.41 Cash after chg. in Working capital 69.21 111.49 -74.62 -35.31 52.29 16.89 17.71 63.41 40.73 54.34 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -37.15 -38.12 -16.55 -24.93 -1.46 -5.88 -0.34 0.00 0.00 0.13 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -4.40 Cash From Investing Activity -321.51 -83.30 -46.51 -31.68 -70.35 -12.46 -13.05 -26.93 -13.60 -27.30 Net Fixed Assets -175.29 27.27 -35.47 24.52 123.41 135.60 113.16 31.96 -8.08 -7.02 Net Investments -78.80 -8.34 -0.05 0.99 0.00 -1.07 0.20 -0.22 0.00 0.25 Others -67.42 -102.23 -10.99 -57.19 -193.76 -146.99 -126.41 -58.67 -5.52 -20.53 Cash from Financing Activity 299.89 5.20 143.54 66.33 47.27 5.49 -0.44 -37.77 -23.72 -27.26 Net Cash Inflow / Outflow 10.44 -4.72 5.86 -25.58 27.75 4.04 3.88 -1.29 3.40 -4.49 Opening Cash & Equivalents 16.95 21.67 15.80 41.39 13.64 9.60 5.72 7.00 3.60 8.85 Closing Cash & Equivalent 27.38 16.95 21.67 15.80 41.39 13.64 9.60 5.72 7.00 4.36

Financial Ratios

Consolidated /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 21.56 17.39 15.26 11.97 8.92 6.83 6.17 5.57 4.99 4.65 ROA 6.77% 9.30% 4.32% 10.75% 12.49% 5.05% 4.73% 4.59% 4.28% 3.05% ROE 9.81% 13.29% 6.84% 20.77% 26.61% 11.06% 10.84% 11.00% 10.69% 7.84% ROCE 13.29% 17.71% 9.15% 23.73% 24.54% 10.82% 7.74% 9.26% 9.17% 6.60% Fixed Asset Turnover 2.76 3.11 2.70 2.91 1.92 1.12 0.86 0.62 0.60 0.51 Receivable days 71.69 67.93 65.07 47.52 45.43 56.08 59.08 62.91 54.48 50.93 Inventory Days 59.47 51.22 64.01 53.88 49.56 51.46 41.93 44.40 34.44 30.13 Payable days 118.96 96.93 92.69 81.12 92.58 79.07 88.97 104.24 84.35 83.75 Cash Conversion Cycle 12.19 22.22 36.39 20.28 2.41 28.47 12.04 3.07 4.58 -2.69 Total Debt/Equity 0.07 0.03 0.03 0.03 0.04 0.04 0.47 0.53 0.22 0.20 Interest Cover 20.37 43.45 32.83 52.75 53.71 20.05 14.82 7.08 4.10 2.50

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 21.10 16.58 14.73 11.56 8.47 6.32 5.63 5.02 4.36 4.02 ROA 7.68% 8.04% 3.55% 10.55% 12.76% 5.25% 4.80% 5.30% 4.45% 2.53% ROE 11.78% 12.08% 5.93% 21.79% 29.20% 12.50% 12.04% 14.10% 12.54% 7.35% ROCE 15.48% 16.82% 8.40% 24.86% 27.13% 12.05% 10.01% 14.05% 10.18% 6.29% Fixed Asset Turnover 2.50 2.65 2.23 2.49 1.72 1.04 0.82 0.60 0.58 0.49 Receivable days 65.45 63.50 66.16 51.04 49.10 58.07 60.70 64.63 55.44 53.22 Inventory Days 55.26 51.55 64.98 53.23 48.20 49.78 40.63 42.59 32.73 29.27 Payable days 107.94 93.67 98.32 86.93 94.60 79.06 88.85 103.38 82.97 83.88 Cash Conversion Cycle 12.78 21.38 32.82 17.35 2.71 28.78 12.48 3.85 5.20 -1.39 Total Debt/Equity 0.07 0.03 0.03 0.03 0.04 0.05 0.52 0.06 0.25 0.22 Interest Cover 19.59 37.50 29.15 53.22 56.09 20.71 14.83 7.83 4.13 2.21

Top Investors:

pinfold overseas limited

Annual Reports:

News Update:

Morepen Laboratories’ arm executes JV agreement with Bimedical FZE
9th Sep 2025, 09:37 AM

The proposed JV company will carry on the business of manufacturing, trading and selling of medical devices related products
Read More
Morepen Laboratories - Quarterly Results
6th Aug 2025, 14:47 PM

Read More
Morepen Laboratories’ arm to incorporate wholly owned subsidiary
25th Jul 2025, 17:50 PM

The company will indirectly hold 60% of the equity shares in the proposed new step-down subsidiary through MML
Read More
Morepen Laboratories incorporates step-down subsidiary in Dubai
23rd Jul 2025, 11:08 AM

The newly formed company will engage in the sales & marketing of medical devices’ products in the international market including Dubai, UAE, and others
Read More
Morepen Laboratories incorporates wholly owned subsidiary in Dubai
19th Jun 2025, 10:52 AM

The said WOS has been incorporated for trading in pharmaceuticals/ medicines (outside UAE)
Read More

Morepen Laboratories Ltd.

Pharmaceuticals & Drugs - API

BSE: 500288 | NSE: MOREPENLAB

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Morepen Laboratories Ltd.

Pharmaceuticals & Drugs - API

BSE: 500288 | NSE: MOREPENLAB

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: